as 85

AS-85 is a cell permeable ASH1L inhibitor with anti-leukemic activity, inhibits the growth of leukemic cells, increases cLogP, decreases tPSA, and can be used in the study of leukemia.

Decyclopropane, also known as HG-7-85-01, is a chemical compound with ABL inhibitor properties. It binds to the IAP ligand through a linker, resulting in the formation of SNIPER [1].

α-Glucosidase-IN-85 (Compound 8D1) functions as an inhibitor of α-Glucosidase, with an IC50 of 5.43 μM. This compound is useful for research related to type 2 diabetes.

AChE-IN-85 (Compound 7k) is an acetylcholinesterase inhibitor with an IC50 of 0.083 μM. It reduces nitric oxide (NO) release, the production of TNF-α and IL-1β, as well as levels of LDH and ROS, and inhibits Aβ42 aggregation. AChE-IN-85 exhibits anti-inflammatory and neuroprotective effects and is applicable for research on diseases such as Alzheimer's.

HIV-1-IN-85 is an orally active HIV-1 inhibitor with an IC50 of 72 nM. It exhibits potent inhibitory activity against wild-type (WT) HIV-1 and single mutant strains resistant to non-nucleoside reverse transcriptase inhibitors (NNRTIs), such as L100I, K103N, Y181C, Y188L, and E138K. Additionally, it shows moderate inhibitory activity against double mutant strains (F227L+V106A, RES056). In ICR mice, HIV-1-IN-85 demonstrates good in vivo safety and is suitable for research on HIV-1 infection.

ALK5-IN-85 (Compound 19) is an inhibitor of TGFβRI (ALK5) with an IC50 of less than 100 nM. It can be used for the treatment of respiratory diseases such as idiopathic pulmonary fibrosis, asthma, chronic obstructive pulmonary disease, and lung cancer, as well as for research on skin and ocular fibrotic diseases.

Tubulin polymerization-IN-85 (Compound C21) is a microtubule polymerization inhibitor with an IC50 value of 1.59 μM, targeting the colchicine binding site. It exhibits antiproliferative activity against HeLa, HepG2, MCF-7, and A549 cells with IC50 values of 0.08, 0.21, 0.27, and 0.32 μM, respectively, while demonstrating low toxicity to normal renal epithelial 293T cells (IC50 value of 187 μM). Tubulin polymerization-IN-85 induces G2/M phase arrest and triggers apoptosis in cancer cells. It downregulates the expression of Bcl-2, Bcl-xl, Mcl-1, Cyclin B1, cdc25, and cdc2 proteins, and upregulates P53, P21, Bad, and Bax levels. This compound is applicable in cancer research, such as cervical cancer studies.

PKCε (85-92) (ψεRACK) is a peptide and selective PKCε activator that does not affect the activity of other PKC isozymes.PKCε (85-92) induces a pro-angiogenic response in endothelial cells, promotes FGF-2 cytosolization, and regulates VEGF activity.

Compound 24f, an antifungal agent also known as 'Antifungal agent 85,' demonstrates potent antibacterial properties, exhibiting minimum inhibitory concentration (MIC) values ranging from 2.5 to 10 μM against diverse Gram-positive bacteria [1].

HG-7-85-01-NH2, as the ligand for SNIPER(ABL)-033, effectively induces the reduction of BCR-ABL protein. This is achieved through SNIPER(ABL)-033, which connects HG-7-85-01 (an ABL inhibitor) to an LCL161 derivative (an IAP ligand) using a linker, demonstrating a DC50 value of 0.3 μM [1].

HSD17B13-IN-85 (186) serves as an inhibitor of 17β-Hydroxysteroid dehydrogenases (HSD17B13), exhibiting potent activity with an IC 50 of less than 0.1 μM for Estradiol. It is primarily utilized in the study of NAFLD (Nonalcoholic fatty liver diseases) [1].

Tween 85 is a nonionic surfactant classified under ethoxylated sorbitan esters. It serves as an emulsifier and solubilizer across various industries, including pharmaceuticals, cosmetics, and food. Owing to its ability to blend oily and aqueous components, it is often utilized in the formulation of creams, lotions, and ointments. Additionally, it functions as a pigment dispersant in the production of paints and coatings.

Chitosan (85%-90% deacetylated, mushroom) is a biochemical reagent that functions as a flocculant, protein precipitant, encapsulating agent, and aqueous thickener.

(R)-BAY-85-8501 is the less active enantiomer of BAY-85-8501, a selective and potent Human Neutrophil Elastase (HNE) inhibitor with an IC50 of 65 pM.

BAY-85-8501 is a selective, reversible, and potent inhibitor of Human Neutrophil Elastase (HNE) with an IC50 of 65 pM.

TX1-85-1 induces partial degradation of Her3 protein and attenuates Her3-dependent signaling. TX1-85-1 is an irreversible Her3 inhibitor (IC50: 23 nM). TX1-85-1 is also the first selective Her3 ligand, which forms a covalent bond with Cys721 located in th

HDAC-IN-85 (Compound 1) is an HDAC inhibitor capable of crossing the blood-brain barrier. It exhibits inhibitory effects on brain tumor cell lines and can induce acetylation, resulting in DNA double-strand breaks and promoting RAD51 ubiquitination, which disrupts the DNA repair process. HDAC-IN-85 is applicable in studies of glioblastoma.

NLRP3-IN-85 (compound 5d) is a potent inhibitor of NLRP3 that operates independently of mitochondrial membrane potential (ΔΨm). It protects mitochondria from oxidative stress and inflammatory damage while inhibiting key inflammatory factors (NO, TNF-α, IL-6). NLRP3-IN-85 alleviates acute lung injury in mice and reduces paw edema in rats, making it useful for acute lung injury (ALI) research.

7U-85 Hydrochloride, a DNA-directed DNA polymerase inhibitor, is used potentially for the treatment of cancer.

A 85 4777, a homoperazine derivative, is an anti-inflammatory agent with nonclassical immunosuppressive properties.

AC 85 is a bamifylline metabolite in human plasma.

AG 85 is a major secretion protein of Mycobacterium tuberculosis.

AG 85-12 is a mimic of the C-terminal portion of angiotensin I.

HG-7-85-01 is a novel ATP-competitive and type II tyrosine kinase inhibitor targeting both wild-type and watchman mutant BCR-ABL, PDGFRα, Kit, and Src kinases, with inhibitory effects on the proliferation of a variety of cancer cell lines, leading to G0/G1-phase blockade and apoptosis induction in BCR-ABL-expressing cells.